Related Experiment Videos

Important predictor of mortality in patients with end-stage liver disease

Hyung Joon Kim1, Hyun Woong Lee

  • 1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. mdjoon@cau.ac.kr

Clinical and Molecular Hepatology
|July 10, 2013
PubMed

Insights

Child-Pugh and Model for End-Stage Liver Disease (MELD) scores are key for assessing liver disease prognosis. This review details their roles and updated versions in predicting outcomes for end-stage liver disease patients.

Area of Science:

  • Hepatology
  • Clinical Medicine
  • Medical Prognostics

Background:

  • Prognosis is crucial for end-stage liver disease (ESLD) management.
  • The Child-Pugh score has been a long-standing reference for cirrhosis prognosis.
  • Limitations exist for established prognostic models.

Purpose of the Study:

  • To review prognostic factors in ESLD.
  • To focus on the comparative roles of Child-Pugh and MELD scores.
  • To highlight advancements in liver disease prognostication.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of prognostic models for ESLD.
  • Comparison of Child-Pugh score and MELD score performance.

Main Results:

  • Child-Pugh score remains a robust predictor, with its components being significant.
  • The Model for End-Stage Liver Disease (MELD) score offers a modern alternative for severity and mortality risk assessment.
  • Modified MELD scores (MELD-Na, Delta MELD) address MELD's weaknesses and have been validated.

Conclusions:

  • Both Child-Pugh and MELD scores are vital for ESLD prognosis.
  • Understanding these scores and their modifications aids clinical decision-making.
  • Continued research refines prognostic accuracy in liver disease.

Keywords:
Child scoreCirrhosisMELD score

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...